Supreme Court’s Tariffs Arguments Were a Bloodbath for Trump
Digest more
Two new studies appearing in Annals of Allergy Asthma & Immunology and being presented at the American College of Allergy, ...
Oral semaglutide improved glycemic parameters and cardiovascular risk factors for adults with overweight or obesity, with ...
Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Tuesday that Arbli (losartan potassium) Oral Suspension, 10 mg/mL, has ...
Navar presented the results of the phase 3 CORALreef Lipids trial, evaluating the oral PCSK9 inhibitor enlicitide in adult ...
If you’ve heard the buzz about oral probiotics, lozenges or melts that deliver beneficial bacteria to your mouth, you’re not ...
A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...
MedPage Today on MSN
Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor
N EW ORLEANS -- Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic ...
A new study links gum disease and cavities to an 86 per cent higher risk of ischaemic stroke, highlighting why oral health is ...
Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...
Cardiologist Dr. Pradip Jamnadas has revealed that poor oral hygiene may predict heart disease, as harmful mouth bacteria can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results